Development and evaluation of a kit formulation for the preparation of 99mTc-DMP-HSA, a new tracer agent for radionuclide ventriculography

Nucl Med Biol. 1997 Aug;24(6):571-8. doi: 10.1016/s0969-8051(97)00019-x.

Abstract

This study presents the development of a kit formulation for the preparation of 99mTc-DMP-HSA, followed by a comparison of such kit-prepared 99mTc-DMP-HSA to 99mTc-RBCs in a volunteer. Reconstitution of the labeling kits with up to 5.55 GBq 99mTc afforded 99mTc-DMP-HSA preparations with a > 95% radiochemical purity for up to 8 h. Only minor differences were observed in the global distribution of both tracer agents, whereas the calculated ejection fractions were almost identical. The effective dose equivalent of 99mTc-DMP-HSA is 8.68 microSv/MBq.

MeSH terms

  • Humans
  • Male
  • Organotechnetium Compounds* / chemistry
  • Organotechnetium Compounds* / pharmacokinetics
  • Quality Control
  • Radiation Dosage
  • Radionuclide Ventriculography*
  • Reagent Kits, Diagnostic
  • Sulfhydryl Compounds* / chemistry
  • Sulfhydryl Compounds* / pharmacokinetics
  • Technetium Tc 99m Aggregated Albumin* / chemistry
  • Technetium Tc 99m Aggregated Albumin* / pharmacokinetics

Substances

  • Organotechnetium Compounds
  • Reagent Kits, Diagnostic
  • Sulfhydryl Compounds
  • Technetium Tc 99m Aggregated Albumin
  • technetium Tc 99m 2,3-dimercaptopropionic acid